
Okay, Computer: Ro CEO Zach Reitano on Weight Loss Drugs
RiskReversal Pod
00:00
Novo Nordisk's Row Body Program Is in Short Supply
Wigovie, Ozempic and Sixenda are all in short supply. Wigovie is a daily injection where patients see about 9% weight loss over the course of a year. We've proactively messaged patients both before on our landing page as well as right after they sign up. And we're doing whatever we can to add more drugs to the formulary by crediting patients,. But this is going to be a challenging moment for us.
Play episode from 14:23
Transcript


